
    
      Participants are randomly assigned to treatment with sertraline (range 25-125 mg per day) or
      identical placebo for 24 weeks. There are 8 scheduled in-person visits in the 24 weeks.
      Visits include neuropsychological testing. Caregivers are asked to are the patient on a Daily
      Affect Diary for 6 weeks during the study period. Telephone followup is done at weeks 36 and
      48. Both groups receive caregiver support/education.
    
  